Pulmonary Drug Delivery Systems Market

Report code : VMI286302 |
Industry : Healthcare and Pharmaceuticals

Published On : Aug 2019 |
Pages : 99 |
Format :
Request Sample
Request Discount

Pulmonary Drug Delivery Systems Market Size And Forecast
According to Verified Market Research, the global pulmonary drug delivery systems market was valued at USD 39.97 Billion in 2018 and is projected to reach USD 58.07 Billion by 2026, growing at a CAGR of 4.8% from 2019 to 2026.
The latest survey on Global Pulmonary Drug Delivery Systems Market is conducted covering various organizations of the industry from different geographies to come up with a 100+ page report. The study is a perfect mix of qualitative and quantitative information highlighting key market developments, challenges that industry and competition are facing along with gap analysis and new opportunities available and trend in the Pulmonary Drug Delivery Systems Market. The report bridges the historical data from 2013 to 2018 and forecasted till 2026. The report aims to present the analysis of Global Pulmonary Drug Delivery Systems Market By Procedure, By Gender, By Service Provider, By Region - North America, Europe, South America, Asia-Pacific, Middle East, and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities.
What is Pulmonary Drug Delivery Systems?
Pulmonary drug delivery system is a method of delivery of drugs to the lungs for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary diseases, chronic bronchitis, and emphysema. This method is most effective means of drug delivery because the lungs have high capillary network, high blood circulation and it have been in use for more than six decades.
Global Pulmonary Drug Delivery Systems Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Recent advancement in pulmonary drug delivery devices and methods, increase in smoking, rise in respiratory diseases, gastrointestinal upset, and minimum dose requirement are the driving factors that will affect the growth of the pulmonary drug delivery market. However, low efficiency of system, poor formulation stability for drug, and improper dosing reproducibility are some of the restraints hamper the growth of the global pulmonary drug delivery system.
Verified Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The "Global Pulmonary Drug Delivery Systems" is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market.

Global Pulmonary Drug Delivery Systems Competitive Landscape
The "Global Pulmonary Drug Delivery Systems Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as AstraZeneca Plc., Boehringer Ingelheim GmbH, GlaxoSmithKline Plc, Merck & Co., Teva Pharmaceutical Industries Ltd., MannKind Corporation, Hoffmann-La Roche Ltd, gilbert technologies, Philips Respironics, Novartis AG. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.

1INTRODUCTION OF GLOBAL PULMONARY DRUG DELIVERY SYSTEMS 

1.1 Overview of the Market

1.2 Scope of Report

1.3 Assumptions


2 EXECUTIVE SUMMARY


3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining

3.2 Validation

3.3 Primary Interviews

3.4 List of Data Sources


4 GLOBAL PULMONARY DRUG DELIVERY SYSTEMS OUTLOOK

4.1 Overview

4.2 Market Dynamics

4.2.1 Drivers

4.2.2 Restraints

4.2.3 Opportunities

4.3 Porters Five Force Model


5 GLOBAL PULMONARY DRUG DELIVERY SYSTEMS MARKET, BY PRODUCT TYPE

5.1 Dry powder inhaler

5.2 Metered dose inhaler

5.3 Nebulizer

5.4 Others


6 GLOBAL PULMONARY DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION

6.1 Asthma

6.2 Cystic fibrosis

6.3 COPD

6.4 Others


7 GLOBAL PULMONARY DRUG DELIVERY SYSTEMS MARKET, BY GEOGRAPHY

7.1 Overview

7.2 North America 

7.2.1 U.S.

7.2.2 Canada

7.2.3 Mexico

7.3 Europe 

7.3.1 Germany

7.3.2 U.K.

7.3.3 France

7.3.4 Rest of Europe

7.4 Asia Pacific 

7.4.1 China

7.4.2 Japan

7.4.3 India

7.4.4 Rest of Asia Pacific

7.5 Rest of the World

7.5.1 Middle East and Africa

7.5.2 South America

8  GLOBAL PULMONARY DRUG DELIVERY SYSTEMS COMPETITIVE LANDSCAPE

8.1 Overview

8.2 Company Market ranking

8.3 Key Development Strategies


9 COMPANY PROFILES

9.1 AstraZeneca Plc.

9.1.1 Overview

9.1.2 Financial Performance

9.1.3 Product Outlook

9.1.4 Key Developments

9.2 Boehringer Ingelheim GmbH

9.2.1 Overview

9.2.2 Financial Performance

9.2.3 Product Outlook

9.2.4 Key Developments

9.3 GlaxoSmithKline Plc.

9.3.1 Overview

9.3.2 Financial Performance

9.3.3 Product Outlook

9.3.4 Key Developments

9.4 Merck & Co.

9.4.1 Overview

9.4.2 Financial Performance

9.4.3 Product Outlook

9.4.4 Key Developments

9.5 Teva Pharmaceutical Industries Ltd.

9.5.1 Overview

9.5.2 Financial Performance

9.5.3 Product Outlook

9.5.4 Key Developments

9.6 MannKind Corporation  

9.6.1 Overview

9.6.2 Financial Performance

9.6.3 Product Outlook

9.6.4 Key Developments

9.7 Hoffmann-La Roche Ltd.

9.7.1 Overview

9.7.2 Financial Performance

9.7.3 Product Outlook

9.7.4 Key Developments

9.8 Gilbert Technologies

9.8.1 Overview

9.8.2 Financial Performance

9.8.3 Product Outlook

9.8.4 Key Developments

9.9 Philips Respironics

9.9.1 Overview

9.9.2 Financial Performance

9.9.3 Product Outlook

9.9.4 Key Developments

9.10 Novartis AG.

9.10.1 Overview

9.10.2 Financial Performance

9.10.3 Product Outlook

9.10.4 Key Developments


10 APPENDIX

10.1 Related Research

Global Fiber Placement Systems Market Research Report 2019-2023

Published Date : Oct 2019

Fiber placement systems are designed for dexterity and flexibility for production of wrinkle-free lay-up of convex and concave parts. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Fiber Placement Systems Report by Ma...

Global Tape Layer Systems Market Research Report 2019-2023

Published Date : Oct 2019

Tape Laying involves placing typically a single end of fiber tape or fabric either binder infused or resin impregnated, onto a flat to moderately curved surface. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Tape Lay...

Global Seismic Isolation Systems Market Research Report 2019-2023

Published Date : Oct 2019

Seismic Isolation Systems is the system used to reduce the effects of earthquake ground shaking on structure, their components and protect them from damaging. The system decouples the building or structure from the horizontal components of the ground motion by interposing structural elements with lo...

Global Automotive Gear Shift Systems Market Research Report 2019-2023

Published Date : Oct 2019

An automotive gear shift system is an interface that keeps the engine rotation levels at desired vehicle speeds. It consists of a shifter housing, gear selector cables, bezels, and buttons. It is of two types: manual and automatic. Asia-Pacific region is the largest and fastest-growing market of Aut...

Global X-ray Imaging Systems Market Research Report 2019-2023

Published Date : Oct 2019

X-rays make up X-radiation, a form of high-energy electromagnetic radiation. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. X-ray Imaging Systems Report by Material, Application, and Geography - Global Forecast to 202...

Global Advanced Ultrasound Imaging Systems Market Research Report 2019-2023

Published Date : Oct 2019

An ultrasound scan is a medical test that uses high-frequency sound waves to capture live images of internal body parts. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Advanced Ultrasound Imaging Systems Report by Mat...

Global Optical Coating Systems Market Research Report 2019-2023

Published Date : Oct 2019

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Optical Coating Systems Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world's major ...

Global Sexually Transmitted Disease (STD ) Drug Market Research Report 2019-2023

Published Date : Oct 2019

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Sexually Transmitted Disease (STD ) Drug Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on t...

Global Manufacturing Execution Systems (MES) Market Research Report 2019-2023

Published Date : Oct 2019

Manufacturing execution systems (MES) are computerized systems used in manufacturing, to track and document the transformation of raw materials to finished goods. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Manufac...

Global Natalizumab Drug Market Research Report 2019-2023

Published Date : Oct 2019

Tysabri (natalizumab) is amonoclonal antibodyused in to treat relapsing forms of multiple sclerosis. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Natalizumab Drug Report by Material, Application, and Geography - Glo...